M H van Rijswijk
Overview
Explore the profile of M H van Rijswijk including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
81
Citations
2413
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tran L, Huitema A, van Rijswijk M, Dinant H, Baars J, Beijnen J, et al.
Hum Antibodies
. 2011 May;
20(1-2):29-35.
PMID: 21558621
Introduction: Visualization of the CD20-antigen expression could provide a tool to localize sites of inflammation and could be of additive value in the diagnosis, and subsequently, in the treatment follow-up...
2.
Westra J, Bijzet J, Doornbos-van der Meer B, van Rijswijk M, Limburg P
Ann Rheum Dis
. 2005 Nov;
65(7):929-35.
PMID: 16269426
Background: Inhibition of intracellular signal transduction is considered to be an interesting target for treatment in inflammation. p38 MAPK inhibitors, especially, have been developed and are now in phase II...
3.
Westra J, Limburg P, de Boer P, van Rijswijk M
Ann Rheum Dis
. 2004 Oct;
63(11):1453-9.
PMID: 15479895
Objective: To investigate the effect of the p38 mitogen activated protein kinase (MAPK) inhibitor RWJ 67657 on inflammatory mediator production by rheumatoid synovial fibroblasts (RSF). Methods: RSF were pretreated with...
4.
Doeglas D, Suurmeijer T, van den Heuvel W, Krol B, van Rijswijk M, van Leeuwen M, et al.
Qual Life Res
. 2004 Aug;
13(6):1053-65.
PMID: 15287272
Objective: First, to investigate the patterns of functional ability, depressive feelings, and social support in early stage rheumatoid arthritis (RA) patients. Second, to demonstrate the stress buffering effect of social...
5.
Hazenberg B, van Gameren I, Bijzet J, Jager P, van Rijswijk M
Neth J Med
. 2004 Jul;
62(4):121-8.
PMID: 15255082
Amyloidosis is a group of diseases, all characterised by deposition of protein fibrils with a beta-sheet structure. This structure generates affinity of amyloid for Congo red dye and is resistant...
6.
Bijl M, Bootsma H, Van Der Geld Y, Limburg P, Kallenberg C, van Rijswijk M
Ann Rheum Dis
. 2004 Jun;
63(7):831-5.
PMID: 15194579
Background: Serum amyloid P component (SAP) and acute phase proteins like C-reactive protein contribute to the clearance of apoptotic cells. This response is diminished in systemic lupus erythematosus (SLE). Objectives:...
7.
Posthumus M, Limburg P, Westra J, van Leeuwen M, van Rijswijk M
Clin Exp Rheumatol
. 2003 Aug;
21(4):465-72.
PMID: 12942698
Objective: To evaluate serum matrix metalloproteinase 3 (MMP-3) levels in comparison to C-reactive protein (CRP) in periods with and without progression of radiological damage in patients with early rheumatoid arthritis...
8.
El Mansoury T, Hazenberg B, El Badawy S, Ahmed A, Bijzet J, Limburg P, et al.
Ann Rheum Dis
. 2002 Jan;
61(1):42-7.
PMID: 11779757
Objective: To screen for amyloid and to assess associated clinical and laboratory characteristics in Egyptian patients with rheumatoid arthritis (RA). Methods: Abdominal subcutaneous fat aspirates were consecutively collected from 112...
9.
Posthumus M, Limburg P, Westra J, van Leeuwen M, van Rijswijk M
J Rheumatol
. 2000 Dec;
27(12):2761-8.
PMID: 11128661
Objective: To analyze the clinical significance of serial measurements of serum matrix metalloproteinase 3 (MMP-3) levels in relation to markers of disease activity and radiological progression in early rheumatoid arthritis...
10.
Kroot E, van Leeuwen M, van Rijswijk M, Prevoo M, van t Hof M, van de Putte L, et al.
Ann Rheum Dis
. 2000 Nov;
59(12):954-8.
PMID: 11087698
Objective: To investigate mortality, functional capacity, and prognostic factors for mortality in an inception cohort of patients with recently diagnosed RA followed up for up to 10 years. Methods: The...